Superworth

Booz Allen Hamilton price to sales ratio BAH

Market value divided by revenue over the last twelve months, since 2012.

Today, Oct 23, 2026
0.8×
10-year median
1.4×
Against its 10-year history
8th
percentile: 0 is its lowest day, 100 its highest
10-year range
0.7× to 2.1×
Peer median
1.3×

Booz Allen Hamilton's price to sales ratio is 0.8× as of Oct 23, 2026.

That is below its ten-year median of 1.4×, lower than on 92% of days in the last ten years.

Over that time it ranged from 0.7× in Jun 2026 to 2.1× in Nov 2024.

The median for 7 consulting Services stocks of a similar size is 1.3×.

Price to sales ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far0.8×0.7×1.1×
20250.9×0.8×1.5×
20241.4×1.4×2.1×
20231.7×1.3×1.7×
20221.6×1.2×1.6×
20211.4×1.3×1.7×
20201.5×1.1×1.6×
20191.4×1.0×1.6×
20181.0×0.9×1.2×
20170.9×0.8×1.0×
20161.0×0.7×1.0×
20150.9×0.7×0.9×
20140.8×0.5×0.8×
20130.5×0.3×0.5×
20120.3×0.3×0.5×

Against its peers

Companies in Consulting Services nearest Booz Allen Hamilton's size, closest first, today.

CompanyPrice to sales ratio
BAHBooz Allen Hamilton0.8×
GGenpact LTD1.3×
FCNFTI Consulting1.1×
EFXEquifax3.3×
EXPOExponent5.8×
HURNHuron Consulting1.7×
ASTHAstrana Health0.5×
ICFIICF International0.9×
Peer median1.3×

Where Booz Allen Hamilton ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Booz Allen Hamilton

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.